Up-regulation of CXC Chemokine Receptor 4 Expression in Chronic Atrial Fibrillation Patients with Mitral Valve Disease May Be Attenuated by Renin–Angiotensin System Blockers

Author： Wang XX   Zhang FR   Zhu JH   Xie XD   Chen JZ  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.37, Iss.4, 2009-07, pp. : 1145-1151

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Renin-Angiotensin System Block and Atrial Fibrillation

By  

Current Medicinal Chemistry, Vol. 12, Iss. 11, 2005-06 ,pp. : 1331-1337

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of the Renin-Angiotensin System and Atrial Fibrillation in Heart Failure

By  

Heart Drug, Vol. 5, Iss. 4, 2005-12 ,pp. : 214-219

Karger

Access to resources Recommend Favorite

Angiotensin II receptor blockers in the prevention of atrial fibrillation

By Barra Silvia   Silvestri Nunzia   Vitagliano Giancarlo   Madrid Alfredo   Gaeta Giovanni  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 9, 2009-06 ,pp. : 1395-1411

Informa Healthcare

Access to resources Recommend Favorite

Targeting the renin–angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

By Kjeldsen Sverre E   Lyle Paulette A   Tershakovec Andrew M   Devereux Richard B   Oparil Suzanne   Dahlöf Björn   de Faire Ulf   Fyhrquist Frej   Ibsen Hans   Kristianson Krister   Lederballe-Pedersen Ole   Lindholm Lars H   Nieminen Markku S   Omvik Per   Wedel Hans  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. : 729-745

Informa Healthcare

Access to resources Recommend Favorite

Hematocrit-lowering Effect Following Inactivation of Renin-Angiotensin System with Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 4, 2004-02 ,pp. : 483-486

Bentham Science Publishers

Access to resources Recommend Favorite